 T80 |
 |
Complications following infusion, transfusion and therapeutic injection  |
| |
| Includes |
complications following perfusion
|
| Excludes2 |
bone marrow transplant rejection (T86.01)
febrile nonhemolytic transfusion reaction (R50.84)
fluid overload due to transfusion (E87.71)
posttransfusion purpura (D69.51)
transfusion associated circulatory overload (TACO) (E87.71)
transfusion (red blood cell) associated hemochromatosis (E83.111)
transfusion related acute lung injury (TRALI) (J95.84)
|
| char7Note |
The appropriate 7th character is to be added to each code from category T80
|
| char7Def |
A: initial encounter
D: subsequent encounter
S: sequela
|
|
| |
 T80.0 |
|
Air embolism following infusion, transfusion and therapeutic injection |
|
| |
| T80.1 |
|
Vascular complications following infusion, transfusion and therapeutic injection |
| |
| UseAdditionalCode |
code to identify the vascular complication
|
| Excludes2 |
extravasation of vesicant agent (T80.81-)
infiltration of vesicant agent (T80.81-)
vascular complications specified as due to prosthetic devices, implants and grafts (T82.8-, T83.8-, T84.8-, T85.8-)
postprocedural vascular complications (T81.7-)
|
|
|
| |
| T80.2 |
|
Infections following infusion, transfusion and therapeutic injection |
| |
| UseAdditionalCode |
code to identify the specific infection, such as:
sepsis (A41.9)
|
| UseAdditionalCode |
code (R65.2-) to identify severe sepsis, if applicable
|
| Excludes2 |
infections specified as due to prosthetic devices, implants and grafts (T82.6-T82.7, T83.5-T83.6, T84.5-T84.7, T85.7)
postprocedural infections (T81.4-)
|
|
| |
| T80.21 |
|
Infection due to central venous catheter |
| |
| Infection due to pulmonary artery catheter (Swan-Ganz catheter) |
|
| |
| T80.211 |
|
Bloodstream infection due to central venous catheter |
| |
| Catheter-related bloodstream infection (CRBSI) NOS | | Central line-associated bloodstream infection (CLABSI) | | Bloodstream infection due to Hickman catheter | | Bloodstream infection due to peripherally inserted central catheter (PICC) | | Bloodstream infection due to portacath (port-a-cath) | | Bloodstream infection due to pulmonary artery catheter | | Bloodstream infection due to triple lumen catheter | | Bloodstream infection due to umbilical venous catheter |
|
| | |
| T80.212 |
|
Local infection due to central venous catheter |
| |
| Exit or insertion site infection | | Local infection due to Hickman catheter | | Local infection due to peripherally inserted central catheter (PICC) | | Local infection due to portacath (port-a-cath) | | Local infection due to pulmonary artery catheter | | Local infection due to triple lumen catheter | | Local infection due to umbilical venous catheter | | Port or reservoir infection | | Tunnel infection |
|
| | |
| T80.218 |
|
Other infection due to central venous catheter |
| |
| Other central line-associated infection | | Other infection due to Hickman catheter | | Other infection due to peripherally inserted central catheter (PICC) | | Other infection due to portacath (port-a-cath) | | Other infection due to pulmonary artery catheter | | Other infection due to triple lumen catheter | | Other infection due to umbilical venous catheter |
|
| | |
| T80.219 |
|
Unspecified infection due to central venous catheter |
| |
| Central line-associated infection NOS | | Unspecified infection due to Hickman catheter | | Unspecified infection due to peripherally inserted central catheter (PICC) | | Unspecified infection due to portacath (port-a-cath) | | Unspecified infection due to pulmonary artery catheter | | Unspecified infection due to triple lumen catheter | | Unspecified infection due to umbilical venous catheter |
|
| | | |
| T80.22 |
|
Acute infection following transfusion, infusion, or injection of blood and blood products |
| | |
| T80.29 |
|
Infection following other infusion, transfusion and therapeutic injection |
| |
| |
| T80.3 |
|
ABO incompatibility reaction due to transfusion of blood or blood products |
| |
| Excludes1 |
minor blood group antigens reactions (Duffy) (E) (K) (Kell) (Kidd) (Lewis) (M) (N) (P) (S) (T80.A-)
|
|
| |
| T80.30 |
|
ABO incompatibility reaction due to transfusion of blood or blood products, unspecified |
| |
| ABO incompatibility blood transfusion NOS | | Reaction to ABO incompatibility from transfusion NOS |
|
| | |
| T80.31 |
|
ABO incompatibility with hemolytic transfusion reaction |
| |
| T80.310 |
|
ABO incompatibility with acute hemolytic transfusion reaction |
| |
| ABO incompatibility with hemolytic transfusion reaction less than 24 hours after transfusion | | Acute hemolytic transfusion reaction (AHTR) due to ABO incompatibility |
|
| | |
| T80.311 |
|
ABO incompatibility with delayed hemolytic transfusion reaction |
| |
| ABO incompatibility with hemolytic transfusion reaction 24 hours or more after transfusion | | Delayed hemolytic transfusion reaction (DHTR) due to ABO incompatibility |
|
| | |
| T80.319 |
|
ABO incompatibility with hemolytic transfusion reaction, unspecified |
| |
| ABO incompatibility with hemolytic transfusion reaction at unspecified time after transfusion | | Hemolytic transfusion reaction (HTR) due to ABO incompatibility NOS |
|
| | | |
| T80.39 |
|
Other ABO incompatibility reaction due to transfusion of blood or blood products |
| |
| Delayed serologic transfusion reaction (DSTR) from ABO incompatibility | | Other ABO incompatible blood transfusion | | Other reaction to ABO incompatible blood transfusion |
|
| |
| |
| T80.4 |
|
Rh incompatibility reaction due to transfusion of blood or blood products |
| |
| Reaction due to incompatibility of Rh antigens (C) (c) (D) (E) (e) |
|
| |
| T80.40 |
|
Rh incompatibility reaction due to transfusion of blood or blood products, unspecified |
| |
| Reaction due to Rh factor in transfusion NOS | | Rh incompatible blood transfusion NOS |
|
| | |
| T80.41 |
|
Rh incompatibility with hemolytic transfusion reaction |
| |
| T80.410 |
|
Rh incompatibility with acute hemolytic transfusion reaction |
| |
| Acute hemolytic transfusion reaction (AHTR) due to Rh incompatibility | | Rh incompatibility with hemolytic transfusion reaction less than 24 hours after transfusion |
|
| | |
| T80.411 |
|
Rh incompatibility with delayed hemolytic transfusion reaction |
| |
| Delayed hemolytic transfusion reaction (DHTR) due to Rh incompatibility | | Rh incompatibility with hemolytic transfusion reaction 24 hours or more after transfusion |
|
| | |
| T80.419 |
|
Rh incompatibility with hemolytic transfusion reaction, unspecified |
| |
| Rh incompatibility with hemolytic transfusion reaction at unspecified time after transfusion | | Hemolytic transfusion reaction (HTR) due to Rh incompatibility NOS |
|
| | | |
| T80.49 |
|
Other Rh incompatibility reaction due to transfusion of blood or blood products |
| |
| Delayed serologic transfusion reaction (DSTR) from Rh incompatibility | | Other reaction to Rh incompatible blood transfusion |
|
| |
| |
| T80.A |
|
Non-ABO incompatibility reaction due to transfusion of blood or blood products |
| |
| Reaction due to incompatibility of minor antigens (Duffy) (Kell) (Kidd) (Lewis) (M) (N) (P) (S) |
|
| |
| T80.A0 |
|
Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified |
| |
| Non-ABO antigen incompatibility reaction from transfusion NOS |
|
| | |
| T80.A1 |
|
Non-ABO incompatibility with hemolytic transfusion reaction |
| |
| T80.A10 |
|
Non-ABO incompatibility with acute hemolytic transfusion reaction |
| |
| Acute hemolytic transfusion reaction (AHTR) due to non-ABO incompatibility | | Non-ABO incompatibility with hemolytic transfusion reaction less than 24 hours after transfusion |
|
| | |
| T80.A11 |
|
Non-ABO incompatibility with delayed hemolytic transfusion reaction |
| |
| Delayed hemolytic transfusion reaction (DHTR) due to non-ABO incompatibility | | Non-ABO incompatibility with hemolytic transfusion reaction 24 or more hours after transfusion |
|
| | |
| T80.A19 |
|
Non-ABO incompatibility with hemolytic transfusion reaction, unspecified |
| |
| Hemolytic transfusion reaction (HTR) due to non-ABO incompatibility NOS | | Non-ABO incompatibility with hemolytic transfusion reaction at unspecified time after transfusion |
|
| | | |
| T80.A9 |
|
Other non-ABO incompatibility reaction due to transfusion of blood or blood products |
| |
| Delayed serologic transfusion reaction (DSTR) from non-ABO incompatibility | | Other reaction to non-ABO incompatible blood transfusion |
|
| |
| |
| T80.5 |
|
Anaphylactic reaction due to serum |
| |
| Allergic shock due to serum | | Anaphylactic shock due to serum | | Anaphylactoid reaction due to serum | | Anaphylaxis due to serum |
| Excludes1 |
ABO incompatibility reaction due to transfusion of blood or blood products (T80.3-)
allergic reaction or shock NOS (T78.2)
anaphylactic reaction or shock NOS (T78.2)
anaphylactic reaction or shock due to adverse effect of correct medicinal substance properly administered (T88.6)
other serum reaction (T80.6-)
|
|
| |
| T80.51 |
|
Anaphylactic reaction due to administration of blood and blood products |
| | |
| T80.52 |
|
Anaphylactic reaction due to vaccination |
| | |
| T80.59 |
|
Anaphylactic reaction due to other serum |
| |
| |
| T80.6 |
|
Other serum reactions |
| |
| Intoxication by serum | | Protein sickness | | Serum rash | | Serum sickness | | Serum urticaria |
| Excludes2 |
serum hepatitis (B16-B19)
|
|
| |
| T80.61 |
|
Other serum reaction due to administration of blood and blood products |
| | |
| T80.62 |
|
Other serum reaction due to vaccination |
| | |
| T80.69 |
|
Other serum reaction due to other serum |
| |
| CodeAlso |
, if applicable, arthropathy in hypersensitivity reactions classified elsewhere (M36.4)
|
|
| |
| |
| T80.8 |
|
Other complications following infusion, transfusion and therapeutic injection |
| |
| T80.81 |
|
Extravasation of vesicant agent |
| |
| Infiltration of vesicant agent |
|
| |
| T80.810 |
|
Extravasation of vesicant antineoplastic chemotherapy |
| |
| Infiltration of vesicant antineoplastic chemotherapy |
|
| | |
| T80.818 |
|
Extravasation of other vesicant agent |
| |
| Infiltration of other vesicant agent |
|
| | | |
| T80.82 |
|
Complication of immune effector cellular therapy |
| |
| Complication of chimeric antigen receptor (CAR-T) cell therapy | | Complication of IEC therapy |
| Excludes2 |
adverse effect of immune checkpoint inhibitors and immunostimulant drugs (T45.AX5)
complication of bone marrow transplant (T86.0)
complication of stem cell transplant (T86.5)
|
| UseAdditionalCode |
code to identify the specific complication, such as:
cytokine release syndrome (D89.83-)
immune effector cell-associated neurotoxicity syndrome (G92.0-)
|
|
| | |
| T80.89 |
|
Other complications following infusion, transfusion and therapeutic injection |
| |
| Delayed serologic transfusion reaction (DSTR), unspecified incompatibility |
| UseAdditionalCode |
code to identify graft-versus-host reaction, if applicable, (D89.81-)
|
|
| |
| |
| T80.9 |
|
Unspecified complication following infusion, transfusion and therapeutic injection |
| |
| T80.90 |
|
Unspecified complication following infusion and therapeutic injection |
| | |
| T80.91 |
|
Hemolytic transfusion reaction, unspecified incompatibility |
| |
| Excludes1 |
ABO incompatibility with hemolytic transfusion reaction (T80.31-)
Non-ABO incompatibility with hemolytic transfusion reaction (T80.A1-)
Rh incompatibility with hemolytic transfusion reaction (T80.41-)
|
|
| |
| T80.910 |
|
Acute hemolytic transfusion reaction, unspecified incompatibility |
| | |
| T80.911 |
|
Delayed hemolytic transfusion reaction, unspecified incompatibility |
| | |
| T80.919 |
|
Hemolytic transfusion reaction, unspecified incompatibility, unspecified as acute or delayed |
| |
| Hemolytic transfusion reaction NOS |
|
| | | |
| T80.92 |
|
Unspecified transfusion reaction |
| |
|
| |